Comparison of measles seroconversion rates at 13 months of age between HIV-infected children vaccinated at 12 months of age and HIV-infected children vaccinated at 6 and 12 months of age Throughout study [clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77]

Comparison of measles seroconversion rates at 13 months of age between HIV-infected children vaccinated at 12 months of age and HIV-infected children vaccinated at 6 and 12 months of age Throughout study [clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77]

Participants who receive vaccination at 6 and 12 months of age
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77

Comparison of measles seroconversion rates at 13 months of age between HIV-infected children vaccinated at 12 months of age and HIV-infected children vaccinated at 6 and 12 months of age Throughout study [clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77]

Participants who receive vaccination at 6 and 12 months of age
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77
Bio2RDF identifier
c9a1f0131ab22685f8a303ffcf8ddd77
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77
measure [clinicaltrials_vocabulary:measure]
Comparison of measles seroconv ...... ated at 6 and 12 months of age
time frame [clinicaltrials_vocabulary:time-frame]
description
Participants who receive vaccination at 6 and 12 months of age
identifier
clinicaltrials_resource:c9a1f0131ab22685f8a303ffcf8ddd77
title
Comparison of measles seroconv ...... months of age Throughout study
@en
inDataset
type
label
Comparison of measles seroconv ...... 1f0131ab22685f8a303ffcf8ddd77]
@en